(Q50988033)

English

Amorfrutin B is an efficient natural peroxisome proliferator-activated receptor gamma (PPARγ) agonist with potent glucose-lowering properties.

scientific article published on 18 May 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23680913

Amorfrutin B is an efficient natural peroxisome proliferator-activated receptor gamma (PPARγ) agonist with potent glucose-lowering properties. (English)

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23680913

Frank C Schroeder

9

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23680913

author name string

C Weidner

1

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23680913

S J Wowro

2

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23680913

A Freiwald

3

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23680913

K Kawamoto

4

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23680913

A Witzke

5

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23680913

M Kliem

6

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23680913

K Siems

7

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23680913

L Müller-Kuhrt

8

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23680913

S Sauer

10

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23680913

publication date

18 May 2013

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23680913

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23680913

56

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23680913

8

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23680913

1802-1812

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23680913

https://scigraph.springernature.com/pub.10.1007/s00125-013-2920-2

0 references

Diabetes and obesity: the twin epidemics

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2920-2

21 January 2018

Mechanisms linking obesity to insulin resistance and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2920-2

21 January 2018

The mechanisms of action of PPARs

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2920-2

21 January 2018

Revisiting the rosiglitazone story--lessons learned

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2920-2

21 January 2018

Peroxisome proliferator-activated receptor gamma: the more the merrier?

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2920-2

21 January 2018

Peroxisome proliferator-activated receptor-gamma: too much of a good thing causes harm

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2920-2

21 January 2018

Principles for modulation of the nuclear receptor superfamily

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2920-2

21 January 2018

Selective PPAR modulators, dual and pan PPAR agonists: multimodal drugs for the treatment of type 2 diabetes and atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2920-2

21 January 2018

Amorfrutins are potent antidiabetic dietary natural products

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2920-2

21 January 2018

Structural characterization of amorfrutins bound to the peroxisome proliferator-activated receptor γ

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2920-2

21 January 2018

A transgenic model of visceral obesity and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2920-2

21 January 2018

Pyruvate dehydrogenase kinase 4: regulation by thiazolidinediones and implication in glyceroneogenesis in adipose tissue

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2920-2

21 January 2018

Improvement in insulin resistance and the restoration of reduced phosphodiesterase 3B gene expression by pioglitazone in adipose tissue of obese diabetic KKAy mice.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2920-2

21 January 2018

Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2920-2

21 January 2018

Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2920-2

21 January 2018

Paradoxical HDL-C reduction during rosiglitazone and fibrate treatment.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2920-2

21 January 2018

Inflammatory mechanisms in obesity

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2920-2

21 January 2018

A guide to analysis of mouse energy metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2920-2

21 January 2018

FGF21 and the second coming of PPARγ.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2920-2

21 January 2018

Fibroblast growth factor-21 regulates PPARγ activity and the antidiabetic actions of thiazolidinediones.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2920-2

21 January 2018

Identifiers

10.1007/S00125-013-2920-2

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23680913

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23680913

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50988033&oldid=1162378496"